Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease

被引:11
|
作者
Gao, Lu [1 ]
Zhao, Wei [1 ]
Yang, Jin-Kui [2 ]
Qin, Ming-Zhao [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Geriatr, Beijing 100730, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
来源
DIABETOLOGY & METABOLIC SYNDROME | 2021年 / 13卷 / 01期
关键词
HEART-DISEASE; RISK-FACTORS; CHINESE; MORTALITY; EVENTS; COMPLICATIONS; PREVALENCE; RESTENOSIS; SEVERITY; SYSTEM;
D O I
10.1186/s13098-021-00666-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Atherosclerosis cardiovascular disease (ASCVD) is the main cause of morbidity and mortality in type 2 diabetes mellitus (T2DM). As most diabetic patients with ASCVD are asymptomatic, it is most neglected in clinical practice. For this reason, identifying high-risk ASCVD population with intensified treatment is very important. In recent years, the relationship between diabetic retinopathy (DR) and ASCVD has caused much academic concern, but the results are inconsistent. Moreover, whether all grades of DR increase the risk of ASCVD remains controversial. Most importantly, very few data can be found in China. Objective Our aim is to discuss whether all grades of DR increase the risk of ASCVD after adjustment for the traditional cardiovascular risk factors and to assess the independent contribution of DR to cardiovascular events in patients with T2DM, hoping to provide more evidence for early identification of ASCVD. Research design and methods A total of 425 T2DM patients with complete physical and biochemical data were included in the study. The grade of DR was assessed with two 45 color digital retinal images. Based on the presence of history of ASCVD, 425 T2DM patients were divided into 2 groups: ASCVD group and non-ASCVD group. Results ASCVD patients were older and had a significantly higher fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) and proportion of history of ASCVD. At the same time, they were more likely to be females, and had lower level of alcohol and calculated glomerular filtration rate (eGFR) than non-ASCVD patients. Their trend to develop DR with ASCVD was significantly higher than patients with non-ASCVD (chi(2) = 5.805, P = 0.016). DR was an independent statistical indicator of the presence of ASCVD [odds ratio (OR) (95% CI): 2.321 (1.152-4.678), P = 0.018]. Furthermore, when DR was divided into non-proliferative retinopathy (NPDR) and proliferative retinopathy (PDR) according to its severity, only PDR was significantly associated with incident ASCVD [OR (95% CI): 8.333 (1.813-38.304), P = 0.006]. After adjusting for traditional ASCVD risk factors, such an association still existed [OR (95% CI): 7.466 (1.355-41.137), P = 0.021]. Conclusion DR associates strongly with ASCVD in the Chinese population with T2DM. With the increasing severity of DR, the risk of ASCVD also increases. After adjustment for traditional risk factors, PDR is still an independent risk marker for ASCVD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Ability of Retinopathy to Predict Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
    Gimeno-Orna, Jose A.
    Faure-Nogueras, Eduardo
    Castro-Alonso, Francisco J.
    Boned-Juliani, Beatriz
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (10): : 1364 - 1367
  • [32] HLA typing is not predictive of proliferative diabetic retinopathy in patients with younger onset type 2 diabetes mellitus
    Mimura, T
    Amano, S
    Kato, S
    Araie, M
    Mimura, T
    Funatsu, H
    Kitano, S
    Shimizu, E
    Noma, H
    Yoshino, O
    Hori, S
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (02) : 303 - 305
  • [33] Presence and development of diabetic retinopathy in 16 999 patients with type 1 diabetes in the Danish Registry of Diabetic Retinopathy
    Stokholm, Lonny
    Pedersen, Frederik Norregaard
    Andersen, Nis
    Andresen, Jens
    Bek, Toke
    Dinesen, Sebastian
    Hajari, Javad
    Heegaard, Steffen
    Hojlund, Kurt
    Laugesen, Caroline Schmidt
    Kawasaki, Ryo
    Moller, Soeren
    Schielke, Katja Christina
    Subhi, Yousif
    Thykjaer, Anne Suhr
    Grauslund, Jakob
    ACTA OPHTHALMOLOGICA, 2024, 102 (07) : 805 - 812
  • [34] Current Prevalence and Correlates of Retinopathy in Patients With Type 2 Diabetes
    Pugliese, Giuseppe
    Solini, Anna
    Bonora, Enzo
    Orsi, Emanuela
    Fondelli, Cecilia
    Zerbini, Gianpaolo
    Trevisan, Roberto
    Vedovato, Monica
    Gruden, Gabriella
    Cavalot, Franco
    Cignarelli, Mauro
    Laviola, Luigi
    Morano, Susanna
    Nicolucci, Antonio
    Penno, Giuseppe
    DIABETES, 2012, 61 : A158 - A158
  • [35] The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus
    Michiaki Miyamoto
    Kazuhiko Kotani
    Kenta Okada
    Yasutomo Fujii
    Kei Konno
    Shun Ishibashi
    Nobuyuki Taniguchi
    Acta Diabetologica, 2012, 49 : 63 - 68
  • [36] Association between Cardiac Autonomic Neuropathy, Diabetic Retinopathy and Carotid Atherosclerosis in Patients with Type 2 Diabetes
    Jung, Chan-Hee
    Back, Ae-Rin
    Kim, Kyu-Jin
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Mok, Ji-Oh
    ENDOCRINOLOGY AND METABOLISM, 2013, 28 (04) : 309 - 319
  • [37] The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus
    Miyamoto, Michiaki
    Kotani, Kazuhiko
    Okada, Kenta
    Fujii, Yasutomo
    Konno, Kei
    Ishibashi, Shun
    Taniguchi, Nobuyuki
    ACTA DIABETOLOGICA, 2012, 49 (01) : 63 - 68
  • [38] Proliferative diabetic retinopathy indicative of diabetes
    Ben Mami, F.
    Sellami, H.
    Hassine, M.
    Abdelhadi, H.
    Fendi, O.
    Denmati, S.
    Dakhli, M. S.
    Achour, A.
    DIABETES & METABOLISM, 2009, 35 : A89 - A89
  • [39] Dipeptidyl Peptidase 4 Inhibitors for Type 2 Diabetes and Relationship to Proliferative Diabetic Retinopathy
    Phu, Alexander
    Banghart, Mark
    Bahrainian, Mozhdeh
    Wolf, Risa M.
    Channa, Roomasa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [40] STATIN MEDICATION USE AND THE DEVELOPMENT OF PROLIFERATIVE DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION, AND HYPERLIPIDEMIA
    Han, Y.
    Balkrishnan, R.
    Thompson, D. A.
    Richards, J. E.
    Stein, J. D.
    VALUE IN HEALTH, 2014, 17 (07) : A721 - A721